Protagonist Therapeutics (PTGX) EBIT Margin Growth (3y) (2020 - 2025)
Protagonist Therapeutics (PTGX) EBIT Margin Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 9,942.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 7,794.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Protagonist Therapeutics | 8.88 Bn | 8.88 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 406,652.00 |
| Mar 31, 2025 | 1,389.00 |
| Dec 31, 2024 | 50,641.00 |
| Sep 30, 2024 | -55,687.00 |
| Jun 30, 2024 | 43,249.00 |
| Mar 31, 2024 | 46,904.00 |
| Dec 31, 2023 | 37,937.00 |
| Jun 30, 2022 | -444,104.00 |
| Mar 31, 2022 | 85,690.00 |
| Dec 31, 2021 | 22,542.00 |
| Sep 30, 2021 | -17,634.00 |
| Jun 30, 2021 | -128,430.00 |
| Mar 31, 2021 | -31,180.00 |
| Dec 31, 2020 | -30,214.00 |
| Sep 30, 2020 | -255.00 |